Diversey Recognized With Innovation Award

Diversey was recently recognized by Newsweek and the Leapfrog Group for its Oxivir Tb, which has been rated as a Best Infection Prevention Product in 2021. Diversey’s Oxivir Tb was evaluated and selected, using four criteria: effectiveness, safety (to both patients and healthcare workers), successful real-world implementation and the stability of the company.

“A clean environment is critical to minimize the risk of infection,” says Carolyn Cooke, vice president of Healthcare in North America, Diversey. “Oxivir disinfectants powered by Accelerated Hydrogen Peroxide (AHP) technology, provide an alternative to traditional disinfectants, marrying fast and effective disinfection with safety for users and surfaces. Effective against bacteria, viruses, and fungi in as little as in one minute, including powerful threats like Candida auris and SARS-CoV-2, the pathogen that causes COVID. 

"The Oxivir family of disinfectants has the best possible safety rating, allowing it to be used at the point of care without risk to patients, their loved ones or healthcare personnel. It is non-irritating to skin and eyes, requires no personal protective equipment and is compatible with most common healthcare surfaces and equipment. Peer reviewed studies have demonstrated that this powerful disinfectant has the ability to reduce healthcare associated infections, such as MRSA, VRE and C.difficile, versus traditional disinfectants in healthcare settings.”